Identification of senescence-related molecular subtypes and key genes for prostate cancer

• Published in: Asian journal of andrology Vol. 25; no. 2; pp. 223 - 229
• Main Authors: Feng, De-Chao, Zhu, Wei-Zhen, Shi, Xu, Xiong, Qiao, You, Jia, Wei, Qiang, Yang, Lu
• Format: Journal Article
• Language: English
• Published: China Wolters Kluwer India Pvt. Ltd 01.03.2023; Medknow Publications and Media Pvt. Ltd; Medknow Publications & Media Pvt. Ltd; Wolters Kluwer - Medknow; Wolters Kluwer Medknow Publications
• Subjects: Aldehyde Dehydrogenase, Mitochondrial; Analysis; Cancer; cellular senescence; immune checkpoints; molecular subtypes; prostate cancer; tumor immune environment; DNA binding proteins; Endothelial Cells; Genes; Genetic aspects; Humans; Invited Original; Ligands; Male; Prostate - pathology; Prostate cancer; Prostatectomy; Prostatic Neoplasms - pathology; Proteins; Senescence; Transcription Factors; molecular subtypes; prostate cancer; cellular senescence; tumor immune environment; immune checkpoints
• ISSN: 1008-682X; 1745-7262; 1745-7262; 1008-682X
• DOI: 10.4103/aja202258

We identified distinct senescence-related molecular subtypes and critical genes among prostate cancer (PCa) patients undergoing radical prostatectomy (RP) or radical radiotherapy (RT). We conducted all analyses using R software and its suitable packages. Twelve genes, namely, secreted frizzled-related protein 4 (SFRP4), DNA topoisomerase II alpha (TOP2A), pleiotrophin (PTN), family with sequence similarity 107 member A (FAM107A), C-X-C motif chemokine ligand 14 (CXCL14), prostate androgen-regulated mucin-like protein 1 (PARM1), leucine zipper protein 2 (LUZP2), cluster of differentiation 38 (CD38), cartilage oligomeric matrix protein (COMP), vestigial-like family member 3 (VGLL3), apolipoprotein E (APOE), and aldehyde dehydrogenase 2 family member (ALDH2), were eventually used to subtype PCa patients from The Cancer Genome Atlas (TCGA) database and GSE116918, and the molecular subtypes showed good correlations with clinical features. In terms of the tumor immune environment (TME) analysis, compared with cluster 1, cancer-associated fibroblasts (CAFs) scored significantly higher, while endothelial cells scored lower in cluster 2 in TCGA database. There was a statistically significant correlation between both CAFs and endothelial cells with biochemical recurrence (BCR)-free survival for PCa patients undergoing RP. For the GSE116918 database, cluster 2 had significantly lower levels of CAFs and tumor purity and higher levels of stromal, immune, and Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data (ESTIMATE) scores than cluster 1; in addition, patients with high levels of CAFs, stromal scores, immune scores, and ESTIMATE scores and low levels of tumor purity tended to suffer from BCR. Based on the median of differentially expressed checkpoints, high expression of CD96, hepatitis A virus cellular receptor 2 (HAVCR2), and neuropilin 1 (NRP1) in GSE116918 and high expression of CD160 and tumor necrosis factor (ligand) superfamily member 18 (TNFSF18) in TCGA database were associated with a significantly higher risk of BCR than their counterparts. In conclusion, we first constructed distinct molecular subtypes and critical genes for PCa patients undergoing RP or RT from the fresh perspective of senescence.